Related Experiment Video
Updated: Jul 7, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Computation of the posterior probability of linkage using 'high effect' genetic model priors
1Genetics Program, Boston University School of Medicine, 715 Albany St. L320D, Boston, MA 02118, USA. loguem@bu.edu
Objectives:
The posterior probability of linkage, or PPL, directly measures the probability that a disease gene is linked to a marker. By placing a Bayesian prior on the elements of the genetic model, it allows for an unknown genetic model without the inflationary effects of maximization. The standard technique uses essentially uniform priors over the elements of the penetrance vector. However, much of the parameter space corresponds to models that seem unlikely to yield substantial evidence for linkage: for example, models with very high phenocopy rates.
Methods:
A new class of priors on the elements of the genetic model is examined both theoretically and in simulations. These priors place 0% probability over models with low sibling relative risk, lambda(s).
Results:
Focusing the prior probability on high lambda(s) models does tend to increase the mean PPL for linked markers, and to decrease the mean PPL for unlinked markers. However, the power to detect linkage remains virtually unchanged. Moreover, under these priors, the PPL occasionally yields unacceptably high values under no linkage.
Conclusions:
It appears important to retain prior probability over apparently 'uninformative' genetic models to accurately characterize the amount of evidence for linkage represented by the data.
Related Concept Videos
Probability Laws
Hardy-Weinberg Principle
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
Mechanistic Models: Compartment Models in Individual and Population Analysis
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
